A phase II randomised controlled trial of adjuvant tumour-infiltrating lymphocytes for pretreatment Epstein-Barr virus DNA-selected high-risk nasopharyngeal carcinoma patients
-
Published:2023-09
Issue:
Volume:191
Page:112965
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Author:
Liang Yu-Jing, Chen Qiu-Yan, Xu Jing-Xiao, Liu Xiu-Feng, Xia Jian-Chuan, Liu Li-Ting, Guo Shan-Shan, Song BinORCID, Wang Pan, Li Ji-BinORCID, Liu QingORCID, Mo Hao-Yuan, Guo Ling, Sun Rui, Luo Dong-Hua, He Jia, Liu Yi-Na, Nie Cai-Ping, Tang Lin-Quan, Li JiangORCID, Mai Hai-Qiang
Subject
Cancer Research,Oncology
|
|